- Home
- CGON
CGON
CG ONCOLOGY INC
as 03-25-2025 9:47am EST
Stocks
| Founded: | 2010 | Country: | United States |
| Employees: | N/A | City: | IRVINE |
| Market Cap: | N/A | IPO Year: | 2024 |
| Target Price: | $65.11 | AVG Volume (30 days): | 755.6K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 10 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.69 | EPS Growth: | N/A |
| 52 Week Low/High: | $23.91 - $46.99 | Next Earning Date: | 05-08-2025 |
| Revenue: | $684,000 | Revenue Growth: | 258.12% |
| Revenue Growth (this year): | 158.34% | Revenue Growth (next year): | -20.32% |
Stock Insider Trading Activity of CG ONCOLOGY INC (CGON)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| POST LEONARD E | CGON | Director | Mar 17 '25 | Sell | $28.00 | 1,000 | $28,000.00 | 0 | |
| POST LEONARD E | CGON | Director | Feb 18 '25 | Sell | $28.61 | 1,000 | $28,610.00 | 0 | |
| POST LEONARD E | CGON | Director | Jan 13 '25 | Sell | $29.66 | 1,000 | $29,660.00 | 0 |
Latest CG ONCOLOGY INC News
CGON Breaking Stock News: Dive into CGON Ticker-Specific Updates for Smart Investing
GlobeNewswire
a day ago
Cretostimogene Grenadenorepvec Data Continues to Demonstrate Best-in-Class Durability of Response as well as Consistent and Compelling Safety and Efficacy
GlobeNewswire
13 days ago
CG Oncology to Participate in the 40th Annual European Association of Urology Congress with a Series of Key Presentations and Updates
GlobeNewswire
a month ago
CG Oncology to Present at the TD Cowen 45th Annual Health Care Conference
Insider Monkey
a month ago
Is CG Oncology, Inc. (CGON) An Oversold Biotech Stock to Buy Now?
Insider Monkey
a month ago
Why CG Oncology, Inc. (CGON) is the Most Oversold Pharma Stock to Buy According to Analysts
Insider Monkey
a month ago
Why CG Oncology (CGON) Is the Most Oversold Healthcare Stock to Buy Now
Simply Wall St.
2 months ago
CG Oncology, Inc. (NASDAQ:CGON) is a favorite amongst institutional investors who own 62%
Zacks
2 months ago
Is ANI Pharmaceuticals (ANIP) Stock Outpacing Its Medical Peers This Year?
Compare CGON vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CGON CG ONCOLOGY INC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.